Question 1

What are the three main parenteral routes for drug delivery?

Accepted Answer

The three primary parenteral routes are intravenous (IV), intramuscular (IM), and subcutaneous (SC) injection. IV injection releases the drug directly into the bloodstream for immediate action. IM injection targets muscle tissue, while SC injection reaches the subcutaneous tissue beneath the skin. Each route offers distinct absorption rates and therapeutic applications.

Question 2

How does drug absorption differ between intramuscular and subcutaneous injection sites?

Accepted Answer

Absorption rates vary significantly by injection site. IM drugs in aqueous solutions absorb rapidly, with faster absorption in the deltoid muscle compared to the gluteus maximus. Subcutaneously administered drugs, like insulin and contraceptive implants, demonstrate slow absorption rates, extending their therapeutic effect over longer periods.

Question 3

Why is the parenteral route preferred for certain drugs?

Accepted Answer

The parenteral route bypasses the gastrointestinal tract and delivers drugs directly into systemic circulation, facilitating rapid onset of action. It is the preferred route for drugs that exhibit poor absorption or instability when administered orally. This direct delivery ensures reliable therapeutic outcomes for drugs that cannot be effectively absorbed through enteral routes.

Question 4

What is the difference between bolus injection and infusion for IV drugs?

Accepted Answer

Bolus injection delivers the drug rapidly into the bloodstream for quick effect, used for drugs like tissue plasminogen activator requiring immediate action. In contrast, antibiotics are infused slowly over a prolonged period to ensure sustained therapeutic action and prevent toxicity. The administration method depends on the drug's pharmacological properties and desired clinical outcome.

Question 5

How do depot preparations differ from aqueous solutions in IM administration?

Accepted Answer

IM drugs in aqueous solutions absorb rapidly, providing quick therapeutic onset. Specialized depot preparations, however, release the drug gradually over extended periods, maintaining therapeutic levels longer. This controlled-release approach is advantageous for drugs requiring sustained action, reducing dosing frequency and improving patient compliance.

Question 6

What happens when tissue irritants are injected subcutaneously?

Accepted Answer

Subcutaneous injection of tissue irritants can cause necrosis and intense pain at the injection site. This adverse effect limits the use of certain irritating compounds via the SC route. Healthcare providers must carefully select appropriate parenteral routes based on drug properties to minimize tissue damage and patient discomfort.

Question 7

How does intrathecal delivery bypass the blood-brain barrier?

Accepted Answer

Intrathecal delivery involves injecting drugs directly into the subarachnoid space to reach the brain and spinal cord, bypassing the blood-brain and blood-cerebrospinal fluid barriers that restrict drug entry into the central nervous system. This method is beneficial when rapid effects on the meninges or spinal axis are required, such as in spinal anesthesia or treating severe muscle spasms with baclofen.

약물 전달: 비경구 경로